The Pharma Career Ladder · The country manager · Step 3: Money, pricing and forecast · Lesson 2

Reading a P&L as a commercial leader

The five lines that matter

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

Many commercial leaders read the first line of the P&L carefully and hand the rest to finance.

I understand why. The sales line is the one we are judged on. But in my experience, the lines below it are where most commercial decisions actually show up.

These are the five I read every month.

Gross sales. What we invoiced to the distributor. It tells you what went into the trade, not what patients used.

Net sales. Gross sales after discounts, rebates and returns. This is the real net price you achieved. It is also where month-end deals quietly appear.

Gross margin. Net sales minus the cost of goods, including bonus goods. It tells you whether the volume was worth having.

Commercial spend. Field force, promotion, events, distributor support. What it cost to win the sales.

Contribution. What is left after that. What the country actually adds to the business.

Three habits help.

  • Read net sales before gross sales.
  • Ask why each line moved, not only whether it hit budget.
  • Go through it with the finance manager, then share the story with your managers. When first-line managers see how their choices land on these lines, the conversations change.
“Sales is the first line of the P&L, not the last.”
Reading a P&L as a commercial leader: The five lines that matter

Lesson 2 of 17 in Step 3: Money, pricing and forecast, with the full guide and a checklist for this week.

More lessons in step 3: Money, pricing and forecast

Money, pricing and forecast, in RepPharma

Targets split by rep, product and month

Yearly targets are split by rep, product and month, and sales credit can be moved between reps without changing the company total.

Distributor stock and sell-out

Distributor stock and pharmacy sell-out side by side, with short-expiry lots flagged up to 90 days ahead.

One system for the whole field force

Visits, plans, forecasts, samples, expenses, leaves and approvals, with role-based access from rep to country manager.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.